Business Context and Reporting Period
This Form 8-K is filed by Health Sciences Acquisitions Corporation 2 (the "Company"), a Cayman Islands emerging growth company, on August 6, 2020. The report details the consummation of the Company's Initial Public Offering (IPO) and a simultaneous private placement.
Key Financial Metrics
- Shares Issued: 16,000,000 ordinary shares (including full exercise of the underwriter's over-allotment option).
- Offering Price: $10.00 per ordinary share.
- Gross Proceeds: $160,000,000.
- Trust Account Balance: $160,000,000 deposited as of August 6, 2020, for the benefit of public stockholders.
- Revenue/Profit/Cash Flow: The filing text does not provide operating revenue, profit, or cash flow metrics as this is a pre-operational SPAC IPO filing.
- Debt/Liquidity: Specific debt obligations are not detailed in the text; liquidity is represented by the $160,000,000 in the trust account.
Material Changes
The primary material change is the transition from a private entity to a public company following the IPO. The Company raised $160,000,000 in gross proceeds, which were fully deposited into a trust account. An audited balance sheet reflecting these proceeds is included as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future operations, or detailed risk factors beyond the standard disclosures for an IPO consummation. The primary focus is the completion of the capital raise and the establishment of the trust account.
Investor Verification Checklist
- Verify the full exercise of the underwriter's over-allotment option resulting in 16,000,000 shares sold.
- Confirm the $160,000,000 deposit into the trust account via the audited balance sheet in Exhibit 99.1.
- Review the terms of the simultaneous private placement mentioned but not detailed in this summary text.
- Check the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.